中药制药过程知识系统(PKS)

Search documents
以创新为引擎,康缘药业驱动中药智造新未来
Ren Min Wang· 2025-06-20 10:34
Core Viewpoint - Innovation and adherence are essential for long-term stability in the pharmaceutical industry, with Kangyuan Pharmaceutical leveraging innovation as its core driving force and showcasing resilience and potential in a competitive market [2]. Group 1: Intelligent Manufacturing - Intelligent manufacturing is the key carrier for transforming innovation into core competitiveness for Kangyuan Pharmaceutical, addressing challenges in traditional Chinese medicine production such as standardization and traceability [3]. - The company has embraced the "digital + intelligent" revolution, reconstructing the entire production process of traditional Chinese medicine with advanced technology [3]. - Kangyuan has developed a knowledge system (PKS) based on big data, which acts as the "smart brain" for intelligent production, optimizing process parameters to ensure product quality [3]. Group 2: Research and Development Foundation - The intelligent manufacturing capabilities of Kangyuan are rooted in continuous high-intensity R&D investment and a strong research foundation [4]. - The company engages in significant national research projects, translating research outcomes into intelligent production capabilities [4]. - A virtuous cycle is formed between R&D and intelligent manufacturing, where R&D provides theoretical support and manufacturing offers a platform for rapid and precise conversion of research results [4]. Group 3: Future Outlook - Kangyuan Pharmaceutical aims to deepen its innovation-driven strategy, modernizing and upgrading the entire Chinese medicine industry while contributing to human health with superior solutions [4].